If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
TRULICITY® (dulaglutide): Route of Administration
Trulicity (dulaglutide) should be injected subcutaneously in the abdomen, thigh, or upper arm.
Dulaglutide should be injected subcutaneously in the abdomen, thigh, or upper arm.1
It must not be injected intravenously or intramuscularly.1
Enclosed Prescribing Information
TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly
1. Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Date of Last Review: November 18, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST